Manufacturing, safety and quality control of vaccines part 3

How it’s made

Typically, companies will work independently to complete clinical development plans for a vaccine. Once a vaccine is authorized, manufacturing begins to scale up. The antigen (part of the germ that our immune system reacts to) is weakened or deactivated. To form the full vaccine, all ingredients are combined. The whole process, from preclinical trial to manufacture, can sometimes take over a decade to complete. In search for a COVID-19 vaccine, researchers and developers are working on several different  phases in parallel, to speed up results. It is the scale of the financial and political commitments to development of a vaccine that has allowed this accelerated development to take place. Also nations and international health organizations are working together through COVAX to invest in development capacity upfront to streamline the process, as well as to ensure equitable distribution of vaccines.

About azaleaazelia

A nice person... :)
This entry was posted in Tak Berkategori. Bookmark the permalink.

1 Response to Manufacturing, safety and quality control of vaccines part 3

  1. Pingback: Manufacturing, safety and quality control of vaccines part 3 — MEDICINE FOR ALL – Lolsys Library

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s